These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34435581)

  • 1. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
    Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
    Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
    Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.
    Li S; Lin Q; Shao X; Mou S; Gu L; Wang L; Zhang Z; Shen J; Zhou Y; Qi C; Jin H; Pang H; Ni Z
    Exp Cell Res; 2019 Oct; 383(1):111488. PubMed ID: 31276670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.
    Zeng W; Wu D; Sun Y; Suo Y; Yu Q; Zeng M; Gao Q; Yu B; Jiang X; Wang Y
    Sci Rep; 2021 Sep; 11(1):19305. PubMed ID: 34588488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
    Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
    Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
    Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
    Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCC950 ameliorates ventricular arrhythmia vulnerability induced by heart failure.
    Jiang X; Yang F; Ou D; Huang L; Li H; Lang M
    Bioengineered; 2022 Apr; 13(4):8593-8604. PubMed ID: 35287557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of combination of anakinra and MCC950 against acute lung injury is achieved through suppression of the NF-κB-mediated-MAPK and NLRP3-caspase pathways.
    Wang X; Chen S; Zhao L; Shi X
    Int Immunopharmacol; 2021 Aug; 97():107506. PubMed ID: 34022766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
    Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
    Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
    Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
    J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective NLRP3 inflammasome inhibitor MCC950 improves isoproterenol-induced cardiac dysfunction by inhibiting cardiomyocyte senescence.
    Shi Y; Zhao L; Wang J; Liu S; Zhang Y; Qin Q
    Eur J Pharmacol; 2022 Dec; 937():175364. PubMed ID: 36336012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.
    Li X; Zhu Q; Wang Q; Zhang Q; Zheng Y; Wang L; Jin Q
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):629-640. PubMed ID: 32444995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome.
    He W; Wei J; Liu X; Zhang Z; Huang R; Jiang Z
    Sci Rep; 2024 May; 14(1):11824. PubMed ID: 38782946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling.
    Chen QQ; Wang FX; Cai YY; Zhang YK; Fang JK; Qi LW; Zhang L; Huang FQ
    J Ethnopharmacol; 2021 Apr; 270():113646. PubMed ID: 33264659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
    Qu J; Yuan Z; Wang G; Wang X; Li K
    Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression.
    Li R; Lu K; Wang Y; Chen M; Zhang F; Shen H; Yao D; Gong K; Zhang Z
    Biochem Biophys Res Commun; 2017 Mar; 485(1):69-75. PubMed ID: 28202417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.
    Lv SL; Zeng ZF; Gan WQ; Wang WQ; Li TG; Hou YF; Yan Z; Zhang RX; Yang M
    Acta Pharmacol Sin; 2021 Dec; 42(12):2016-2032. PubMed ID: 34226664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.